$RGLD
ROYAL GOLD INC

2023 Q2 Form 10-Q Financial Statement

#000155837023007915 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $144.0M $170.4M
YoY Change -1.64% 4.95%
Cost Of Revenue $24.64M $27.01M
YoY Change -2.35% 8.64%
Gross Profit $119.4M $97.17M
YoY Change 54.38% 8.41%
Gross Profit Margin 82.89% 57.03%
Selling, General & Admin $9.093M $11.00M
YoY Change -2.35% 23.17%
% of Gross Profit 7.62% 11.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $38.41M $46.33M
YoY Change -12.68% -3.46%
% of Gross Profit 32.17% 47.68%
Operating Expenses $47.51M $57.33M
YoY Change -10.87% 0.72%
Operating Profit $71.90M $86.06M
YoY Change 5.88% 6.8%
Interest Expense -$6.267M -$6.113M
YoY Change 153.62% -985.94%
% of Operating Profit -8.72% -7.1%
Other Income/Expense, Net
YoY Change
Pretax Income $65.63M $79.94M
YoY Change 0.3% -1.63%
Income Tax $2.029M $15.87M
% Of Pretax Income 3.09% 19.85%
Net Earnings $63.45M $63.88M
YoY Change -10.81% -2.74%
Net Earnings / Revenue 44.05% 37.49%
Basic Earnings Per Share $0.97 $0.97
Diluted Earnings Per Share $0.96 $0.97
COMMON SHARES
Basic Shares Outstanding 65.68M 65.64M
Diluted Shares Outstanding 65.76M 65.71M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.2M $126.8M
YoY Change -62.17% -30.97%
Cash & Equivalents $106.2M $126.8M
Short-Term Investments
Other Short-Term Assets $2.375M $2.091M
YoY Change 20.5% -75.5%
Inventory $10.66M $11.60M
Prepaid Expenses
Receivables $36.46M $46.93M
Other Receivables $9.602M $1.724M
Total Short-Term Assets $165.2M $189.2M
YoY Change -51.45% -26.86%
LONG-TERM ASSETS
Property, Plant & Equipment $3.156B $3.191B
YoY Change 32.04% 31.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $547.0K $1.172M
YoY Change 173.5% -49.04%
Other Assets $118.4M $110.5M
YoY Change -3.66% 13.29%
Total Long-Term Assets $3.274B $3.302B
YoY Change 30.32% 30.45%
TOTAL ASSETS
Total Short-Term Assets $165.2M $189.2M
Total Long-Term Assets $3.274B $3.302B
Total Assets $3.440B $3.491B
YoY Change 20.56% 25.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.552M $7.852M
YoY Change 21.01% 25.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.07M $55.00M
YoY Change -1.48% 11.01%
LONG-TERM LIABILITIES
Long-Term Debt $395.5M $496.8M
YoY Change
Other Long-Term Liabilities $9.083M $7.501M
YoY Change 47.24% 16.57%
Total Long-Term Liabilities $404.6M $504.3M
YoY Change 6458.79% 7737.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.07M $55.00M
Total Long-Term Liabilities $404.6M $504.3M
Total Liabilities $616.1M $696.1M
YoY Change 293.99% 384.28%
SHAREHOLDERS EQUITY
Retained Earnings $605.3M $566.5M
YoY Change 28.04% 33.43%
Common Stock $656.0K $656.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.824B $2.783B
YoY Change
Total Liabilities & Shareholders Equity $3.440B $3.491B
YoY Change 20.56% 25.13%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $63.45M $63.88M
YoY Change -10.81% -2.74%
Depreciation, Depletion And Amortization $38.41M $46.33M
YoY Change -12.68% -3.46%
Cash From Operating Activities $107.9M $108.7M
YoY Change -10.21% 7.44%
INVESTING ACTIVITIES
Capital Expenditures $2.670M $0.00
YoY Change -6612.2% -100.0%
Acquisitions
YoY Change
Other Investing Activities $46.00K $197.0K
YoY Change -284.0% 1690.91%
Cash From Investing Activities -$2.624M -$197.0K
YoY Change 3875.76% -99.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $75.00M
YoY Change
Cash From Financing Activities -126.0M -100.2M
YoY Change 442.47% 332.65%
NET CHANGE
Cash From Operating Activities 107.9M 108.7M
Cash From Investing Activities -2.624M -197.0K
Cash From Financing Activities -126.0M -100.2M
Net Change In Cash -20.66M 8.230M
YoY Change -121.32% -79.5%
FREE CASH FLOW
Cash From Operating Activities $107.9M $108.7M
Capital Expenditures $2.670M $0.00
Free Cash Flow $105.3M $108.7M
YoY Change -12.46% -21.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2120000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
189164000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
185833000
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
3191385000
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
3237402000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
110483000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
111287000
CY2023Q1 us-gaap Assets
Assets
3491032000
CY2022Q4 us-gaap Assets
Assets
3534522000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7852000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6686000
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
24642000
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
24627000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8225000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
16065000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14279000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16209000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54998000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63587000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
496817000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
571572000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
136784000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
138156000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7501000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7738000
CY2023Q1 us-gaap Liabilities
Liabilities
696100000
CY2022Q4 us-gaap Liabilities
Liabilities
781053000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65599348
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65592597
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
656000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
656000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2215362000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2213123000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
566545000
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000085535
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-13357
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Royal Gold, Inc
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-0835164
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1144 15th Street, Suite 2500
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
573-1660
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
RGLD
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
527314000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2782563000
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65678346
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126816000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118586000
CY2023Q1 rgld Royalty Receivables
RoyaltyReceivables
46934000
CY2022Q4 rgld Royalty Receivables
RoyaltyReceivables
49405000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1724000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3066000
CY2023Q1 us-gaap Inventory Gross
InventoryGross
11599000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
12656000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2091000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2741093000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
203000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
64071000
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24644000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
12369000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
12376000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2794932000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2753469000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3491032000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3534522000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162355000
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
25020000
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
22639000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11000000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8931000
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1989000
CY2022Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
2221000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46328000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47988000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
84337000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
81779000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
86055000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
80576000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
613000
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2263000
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
975000
CY2023Q1 rgld Interest And Other Expense
InterestAndOtherExpense
9175000
CY2022Q1 rgld Interest And Other Expense
InterestAndOtherExpense
898000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79942000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81266000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15871000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15304000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
64071000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65962000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
196000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
287000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
63875000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
65675000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65594977
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65565735
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65709095
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65644668
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.375
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2753469000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2239000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23166000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8230000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2794932000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2601211000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2266000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
329000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65962000
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
22996000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2646114000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
64071000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
65962000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46328000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47988000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2636000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2124000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
613000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1092000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
688000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-214000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-245000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2471000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-569000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1056000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3118000
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1342000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-518000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
914000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7309000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1166000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-208000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7840000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-10910000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2168000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1039000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
108655000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101133000
CY2022Q1 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
37800000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
197000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-197000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37811000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
75000000
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-397000
CY2022Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
141000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24629000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22978000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-202000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-329000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-100228000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40156000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118586000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143551000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126816000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183707000
CY2023Q1 us-gaap Mineral Properties Gross
MineralPropertiesGross
4871715000
CY2023Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
1680330000
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
3191385000
CY2022Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
4875802000
CY2022Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
1634113000
CY2022Q4 us-gaap Mineral Properties Accumulated Impairment
MineralPropertiesAccumulatedImpairment
4287000
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
3237402000
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
975000
CY2023Q1 rgld Interest And Other Expense
InterestAndOtherExpense
9175000
CY2022Q1 rgld Interest And Other Expense
InterestAndOtherExpense
898000
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
1172000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
373000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1503000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000000
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3183000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
496817000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
575000000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3428000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
571572000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162355000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162355000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2636000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2124000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79942000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81266000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
138890
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
67600
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
63875000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
65675000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65594977
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65565735
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
114118
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
78933
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65709095
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65644668
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162355000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15871000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15304000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
3191385000
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
3237402000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
25020000
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1989000
CY2023Q1 us-gaap Depletion
Depletion
46214000
CY2023Q1 us-gaap Gross Profit
GrossProfit
97169000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162355000
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
22639000
CY2022Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
2221000
CY2022Q1 us-gaap Depletion
Depletion
47863000
CY2022Q1 us-gaap Gross Profit
GrossProfit
89632000
CY2023Q1 us-gaap Gross Profit
GrossProfit
97169000
CY2022Q1 us-gaap Gross Profit
GrossProfit
89632000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11000000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8931000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
114000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
86055000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
80576000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
613000
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2263000

Files In Submission

Name View Source Status
0001558370-23-007915-index-headers.html Edgar Link pending
0001558370-23-007915-index.html Edgar Link pending
0001558370-23-007915.txt Edgar Link pending
0001558370-23-007915-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgld-20230331.xsd Edgar Link pending
rgld-20230331x10q.htm Edgar Link pending
rgld-20230331xex31d1.htm Edgar Link pending
rgld-20230331xex31d2.htm Edgar Link pending
rgld-20230331xex32d1.htm Edgar Link pending
rgld-20230331xex32d2.htm Edgar Link pending
Show.js Edgar Link pending
rgld-20230331_def.xml Edgar Link unprocessable
rgld-20230331_cal.xml Edgar Link unprocessable
rgld-20230331_lab.xml Edgar Link unprocessable
rgld-20230331_pre.xml Edgar Link unprocessable
rgld-20230331x10q_htm.xml Edgar Link completed